Cargando…
Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals
INTRODUCTION: Hydroxychloroquine (HCQ) is a common disease modifying therapy for the treatment of rheumatoid arthritis (RA). Prior research suggests that HCQ may reduce the risk of diabetes mellitus in patients with RA. To investigate the mechanism of this effect, we examined the effect of HCQ on in...
Autores principales: | Mercer, Emileigh, Rekedal, Laura, Garg, Rajesh, Lu, Bing, Massarotti, Elena M, Solomon, Daniel H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446518/ https://www.ncbi.nlm.nih.gov/pubmed/22676348 http://dx.doi.org/10.1186/ar3868 |
Ejemplares similares
-
Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism
por: Qiao, Xin, et al.
Publicado: (2019) -
EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus
por: Obermayer, Anna, et al.
Publicado: (2021) -
Higher Adherence to a Mediterranean Diet Is Associated with Improved Insulin Sensitivity and Selected Markers of Inflammation in Individuals Who Are Overweight and Obese without Diabetes
por: Sood, Surbhi, et al.
Publicado: (2022) -
Triglyceride profiling in adipose tissues from obese insulin sensitive, insulin resistant and type 2 diabetes mellitus individuals
por: Al-Sulaiti, Haya, et al.
Publicado: (2018) -
Comparing the Metabolic Profiles Associated with Fitness Status between Insulin-Sensitive and Insulin-Resistant Non-Obese Individuals
por: AlMuraikhy, Shamma, et al.
Publicado: (2022)